Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evaluating the impact of summer vacation on the visual acuity of AMD patients treated with ranibizumab.

Eye (London, England)·2015
Same author

Identifying Small Molecules which Inhibit Autophagy: a Phenotypic Screen Using Image-Based High-Content Cell Analysis.

Current chemical genomics and translational medicine·2014
Same author

[A rare cause of embolic ischemia of the hand: an isolated aneurism of a branch of the axillary artery].

Journal des maladies vasculaires·2008
Same author

[Value of perfusion MRI in the study of pilocytic astrocytoma and hemangioblastoma: preliminary findings].

Journal of neuroradiology = Journal de neuroradiologie·2008
Same author

[Nontumoral epileptogenic lesions].

Neuro-Chirurgie·2008
Same author

[Perfusion-diffusion 1H spectroscopy: role in the diagnosis and follow-up of supratentorial brain tumours in adults].

Revue neurologique·2006

Related Experiment Video

Updated: Mar 6, 2026

Using Scaffold Liposomes to Reconstitute Lipid-proximal Protein-protein Interactions In Vitro
08:53

Using Scaffold Liposomes to Reconstitute Lipid-proximal Protein-protein Interactions In Vitro

Published on: January 11, 2017

9.4K

In Vitro Characterization of VPS34 Lipid Kinase Inhibition by Small Molecules.

F Fassy1, C Dureuil1, A Lamberton1

  • 1Sanofi, Quai Jules Guesde, Vitry Sur Seine, Paris, France.

Methods in Enzymology
|March 4, 2017
PubMed
Summary

This review details essential in vitro assays for characterizing VPS34 kinase inhibitors, focusing on catalytic and binding activities. It also covers cell-based assays and protein crystallization for drug design.

Keywords:
AutophagyEndosomesLipid kinasePI3KPIK3C3/VPS34Vesicle trafficking

More Related Videos

Assaying the Kinase Activity of LRRK2 in vitro
06:09

Assaying the Kinase Activity of LRRK2 in vitro

Published on: January 18, 2012

23.0K
A Liposome Membrane Permeability Assay for Investigating the Effects of Phosphatidylinositol Phosphate Groups on Membranotropic Action of Venom PLA2
10:31

A Liposome Membrane Permeability Assay for Investigating the Effects of Phosphatidylinositol Phosphate Groups on Membranotropic Action of Venom PLA2

Published on: September 26, 2025

581

Related Experiment Videos

Last Updated: Mar 6, 2026

Using Scaffold Liposomes to Reconstitute Lipid-proximal Protein-protein Interactions In Vitro
08:53

Using Scaffold Liposomes to Reconstitute Lipid-proximal Protein-protein Interactions In Vitro

Published on: January 11, 2017

9.4K
Assaying the Kinase Activity of LRRK2 in vitro
06:09

Assaying the Kinase Activity of LRRK2 in vitro

Published on: January 18, 2012

23.0K
A Liposome Membrane Permeability Assay for Investigating the Effects of Phosphatidylinositol Phosphate Groups on Membranotropic Action of Venom PLA2
10:31

A Liposome Membrane Permeability Assay for Investigating the Effects of Phosphatidylinositol Phosphate Groups on Membranotropic Action of Venom PLA2

Published on: September 26, 2025

581

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Drug Discovery

Background:

  • VPS34 is a class III phosphoinositide 3-kinase crucial for vesicle trafficking and early autophagy.
  • Its role in autophagy makes it a significant target for therapeutic intervention.
  • Advancements in kinase inhibitor optimization highlight VPS34's potential for catalytic inhibition.

Purpose of the Study:

  • To present key in vitro assays for characterizing VPS34 catalytic inhibitors.
  • To guide medicinal chemistry efforts in designing small molecule VPS34 inhibitors.

Main Methods:

  • Catalytic assays (IC50) using purified recombinant VPS34 protein.
  • Binding assays (KD, ka, kd) with purified recombinant VPS34 protein.
  • Cell-based assays (IC50) in GFP-FYVE expressing cell lines.
  • Methodology for VPS34 protein crystallization.

Main Results:

  • Detailed descriptions of various in vitro and cell-based assays for VPS34 inhibitor characterization.
  • Methodology for VPS34 protein crystallization provided.

Conclusions:

  • Standardized assays are crucial for evaluating VPS34 inhibitors.
  • Crystallization data can inform the rational design of novel kinase inhibitors.
  • This review provides a framework for assessing VPS34-targeted therapeutics.